ConductScience.org, home

Paper29348462

Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.

Hang W and 13 others. Oncogene, 2018. Cited by 42 papers, by iCite.

Cite this record

ConductScience Library. Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1. Papers, record 29348462. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29348462

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Piperlongumine and p53-reactivator APR-246 selectively induce cell death in HNSCC by targeting GSTP1.
PubMed
Journal
Oncogene
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
42
iCite
Relative citation ratio, by iCite
1.73
iCite
Revised in PubMed
2026-01-27
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hang WWei
2Yin ZXZhi-Xian
3Liu GGang
4Zeng QQinghua
5Shen XFXiang-Feng
6Sun QHQian-Hui
7Li DDDong-Dong
8Jian YPYong-Ping
9Zhang YHYang-He
10Wang YSYi-Shu
11Quan CSCheng-Shi
12Zhao RXRui-Xun
13Li YLYu-Lin
14Xu ZXZhi-Xiang

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
DioxolanesMajor topic
Gene Expression Regulation, NeoplasticMajor topic
Glutathione S-Transferase piMajor topic
Head and Neck NeoplasmsMajor topic
QuinuclidinesMajor topic
Tumor Suppressor Protein p53Major topic
Animals
Apoptosis
Biomarkers, Tumor
Case-Control Studies
Cell Proliferation
Drug Therapy, Combination
Female
Follow-Up Studies
Humans
Male
Mice
Mice, SCID
Prognosis
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Piperidones

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA133053NCI NIH HHSUnited StatesR01CA133053PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127888811The role of p53 in cancer drug resistance and targeted chemotherapy.Oncotarget2017https://conductscience.org/library/papers/27888811PubMed
226905788Using Sensors and Generators of H2O2 to Elucidate the Toxicity Mechanism of Piperlongumine and Phenethyl Isothiocyanate.Antioxid Redox Signal2016https://conductscience.org/library/papers/26905788PubMed
324091667Piperlongumine induces autophagy by targeting p38 signaling.Cell Death Dis2013https://conductscience.org/library/papers/24091667PubMed
426975633APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines.Cancer Lett2016https://conductscience.org/library/papers/26975633PubMed
524768524Mutant p53 reactivation by small molecules makes its way to the clinic.FEBS Lett2014https://conductscience.org/library/papers/24768524PubMed
623238172Overview of the therapeutic potential of piplartine (piperlongumine).Eur J Pharm Sci2013https://conductscience.org/library/papers/23238172PubMed
726848023Piperlongumine exerts cytotoxic effects against cancer cells with mutant p53 proteins at least in part by restoring the biological functions of the tumor suppressor.Int J Oncol2016https://conductscience.org/library/papers/26848023PubMed
827008382Vitamin E, γ-tocotrienol, Protects Against Buthionine Sulfoximine-Induced Cell Death by Scavenging Free Radicals in SH-SY5Y Neuroblastoma Cells.Nutr Cancer2016https://conductscience.org/library/papers/27008382PubMed
925767602Induction of BCL2-Interacting Killer, BIK, is Mediated for Anti-Cancer Activity of Curcumin in Human Head and Neck Squamous Cell Carcinoma Cells.J Cancer2015https://conductscience.org/library/papers/25767602PubMed
1018035380Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.Mutat Res2008https://conductscience.org/library/papers/18035380PubMed
1127461609Antileukemic effects of piperlongumine and alpha lipoic acid combination on Jurkat, MEC1 and NB4 cells in vitro.J Cancer Res Ther2016https://conductscience.org/library/papers/27461609PubMed
1224857548Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.Mol Cell2014https://conductscience.org/library/papers/24857548PubMed
1316420250Inhibitory effect of piperlonguminine on melanin production in melanoma B16 cell line by downregulation of tyrosinase expression.Pigment Cell Res2006https://conductscience.org/library/papers/16420250PubMed
1427960087Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors.Cancer Cell2016https://conductscience.org/library/papers/27960087PubMed
1524406211The role of reactive oxygen species and metabolism on cancer cells and their microenvironment.Semin Cancer Biol2014https://conductscience.org/library/papers/24406211PubMed
1611875500Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound.Nat Med2002https://conductscience.org/library/papers/11875500PubMed
1728439094Selective Targeting of Cancer Cells by Oxidative Vulnerabilities with Novel Curcumin Analogs.Sci Rep2017https://conductscience.org/library/papers/28439094PubMed
1826963494Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.Cancer Lett2016https://conductscience.org/library/papers/26963494PubMed
1928160777Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.BMC Cancer2017https://conductscience.org/library/papers/28160777PubMed
2023355677Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23355677PubMed

See all 54 referencesDownload CSV of references

Cited by26

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.

PMIDTitleJournalYearIn PapersSource
42939551Advances in p53 Therapies for Oral Squamous Cell Carcinoma: A Literature Review.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42939551PubMed
40775425Network-based approach identifies key genes associated with tumor heterogeneity in HPV positive and negative head and neck cancer patients.Sci Rep2025https://conductscience.org/library/papers/40775425PubMed
40426992Strategies for Anticancer Treatment in p53-Mutated Head and Neck Squamous Cell Carcinoma.Biomedicines2025https://conductscience.org/library/papers/40426992PubMed
39697540Combination of Vitex pseudo-negundo methanolic-extract with cisplatin can induce antioxidant activity and apoptosis in HeLa and Caski cells.Front Pharmacol2024https://conductscience.org/library/papers/39697540PubMed
38275623PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis.Antioxidants (Basel)2023https://conductscience.org/library/papers/38275623PubMed
37736748Oral squamous cell carcinomas: state of the field and emerging directions.Int J Oral Sci2023https://conductscience.org/library/papers/37736748PubMed
37608128Reconstructing the immunosenescence core pathway reveals global characteristics in pan-cancer.Cancer Immunol Immunother2023https://conductscience.org/library/papers/37608128PubMed
37049976Compound 275# Induces Mitochondria-Mediated Apoptosis and Autophagy Initiation in Colorectal Cancer Cells through an Accumulation of Intracellular ROS.Molecules2023https://conductscience.org/library/papers/37049976PubMed
36046754The promising potential of piperlongumine as an emerging therapeutics for cancer.Explor Target Antitumor Ther2021https://conductscience.org/library/papers/36046754PubMed
35071005Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments.Front Oncol2021https://conductscience.org/library/papers/35071005PubMed
34229670Piperlongumine inhibits migration and proliferation of castration-resistant prostate cancer cells via triggering persistent DNA damage.BMC Complement Med Ther2021https://conductscience.org/library/papers/34229670PubMed
34047948Kuanxiong Aerosol () in Treatment of Angina Pectoris: A Literature Review and Network Pharmacology.Chin J Integr Med2021https://conductscience.org/library/papers/34047948PubMed
33946704Glutathione S-Transferases in Cancer.Antioxidants (Basel)2021https://conductscience.org/library/papers/33946704PubMed
33371351STAT3 and p53: Dual Target for Cancer Therapy.Biomedicines2020https://conductscience.org/library/papers/33371351PubMed
33314700A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death.EMBO Mol Med2021https://conductscience.org/library/papers/33314700PubMed
33023080The Application of Next-Generation Sequencing to Define Factors Related to Oral Cancer and Discover Novel Biomarkers.Life (Basel)2020https://conductscience.org/library/papers/33023080PubMed
31739520Piperlongumine Induces Cell Cycle Arrest via Reactive Oxygen Species Accumulation and IKKβ Suppression in Human Breast Cancer Cells.Antioxidants (Basel)2019https://conductscience.org/library/papers/31739520PubMed
31680961Piperlongumine Inhibits Akt Phosphorylation to Reverse Resistance to Cisplatin in Human Non-Small Cell Lung Cancer Cells via ROS Regulation.Front Pharmacol2019https://conductscience.org/library/papers/31680961PubMed
31493144Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.Cell Oncol (Dordr)2019https://conductscience.org/library/papers/31493144PubMed
31334116Ruthenium Complexes With Piplartine Cause Apoptosis Through MAPK Signaling by a p53-Dependent Pathway in Human Colon Carcinoma Cells and Inhibit Tumor Development in a Xenograft Model.Front Oncol2019https://conductscience.org/library/papers/31334116PubMed

See all 26 cited byDownload CSV of cited by

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29348462

GET https://conductscience.org/api/papers/v1/29348462/references?page=2